Mori Arkin, who served as deputy chairman of Perrigo Company (NYSE:PRGO; TASE:PRGO) after selling Israeli company Agis Industries to Perrigo 10 years ago for $850 million in cash and shares, says he will vote against Mylan's $27 billion bid at next week's shareholders meeting. Arkin still holds a 0.5% stake in Perrigo, having originally held a 10% stake. Today he is managing partner of Sphera Global Healthcare Fund, which invests in medical device and biotech companies. Arkin told "Reuters," "Usually, when a good company is acquired, it is for a significant premium. In our case, it's negligible, if at all. If we wait a few months, we would have the same price without all the hassle and risk involved in a Mylan deal." RELATED ARTICLES Perrigo shareholder Meitav DS opposes Mylan bid Mylan chairman to Perrigo: You can't stop takeover Perrigo buys scar management co ScarAway Mylan will make an official offer for Perrigo on Monday. Israeli institutional investor Meitav DS also said that it would vote against accepting Mylan's bid. Published by Globes [online], Israel business news - www.globes-online.com - on September 11, 2015 © Copyright of Globes Publisher Itonut (1983) Ltd. 2015